Regenerative capacity of adipose derived stem cells (ADSCs), comparison with mesenchymal stem cells (MSCs)
L Mazini, L Rochette, M Amine, G Malka - International journal of …, 2019 - mdpi.com
Adipose tissue is now on the top one of stem cell sources regarding its accessibility,
abundance, and less painful collection procedure when compared to other sources. The …
abundance, and less painful collection procedure when compared to other sources. The …
Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation
P Bora, AS Majumdar - Stem cell research & therapy, 2017 - Springer
Adipose/fat tissue provides an abundant source of stromal vascular fraction (SVF) cells for
immediate administration and can also give rise to a substantial number of cultured …
immediate administration and can also give rise to a substantial number of cultured …
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the …
Background aims Adipose tissue is a rich and very convenient source of cells for
regenerative medicine therapeutic approaches. However, a characterization of the …
regenerative medicine therapeutic approaches. However, a characterization of the …
Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells
M Strioga, S Viswanathan, A Darinskas… - Stem cells and …, 2012 - liebertpub.com
Mesenchymal stem/stromal cells (MSCs) comprise a heterogeneous population of cells with
multilineage differentiation potential, the ability to modulate oxidative stress, and secrete …
multilineage differentiation potential, the ability to modulate oxidative stress, and secrete …
The life and fate of mesenchymal stem cells
E Eggenhofer, F Luk, MH Dahlke… - Frontiers in …, 2014 - frontiersin.org
Mesenchymal stem cells (MSC) are present throughout the body and are thought to play a
role in tissue regeneration and control of inflammation. MSC can be easily expanded in vitro …
role in tissue regeneration and control of inflammation. MSC can be easily expanded in vitro …
Comparing the immunomodulatory properties of bone marrow, adipose tissue, and birth-associated tissue mesenchymal stromal cells
P Mattar, K Bieback - Frontiers in immunology, 2015 - frontiersin.org
Mesenchymal stromal cells (MSC) have gained immense attraction in regenerative
medicine, tissue engineering, and immunotherapy. This is based on their differentiation …
medicine, tissue engineering, and immunotherapy. This is based on their differentiation …
The adipose organ at a glance
S Cinti - Disease models & mechanisms, 2012 - journals.biologists.com
The main parenchymal cells of the adipose organ are adipocytes. White adipocytes store
energy, whereas brown adipocytes dissipate energy for thermogenesis. These two cell types …
energy, whereas brown adipocytes dissipate energy for thermogenesis. These two cell types …
[HTML][HTML] Advances in regenerative therapy: A review of the literature and future directions
There is enormous global anticipation for stem cell-based therapies that are safe and
effective. Numerous pre-clinical studies present encouraging results on the therapeutic …
effective. Numerous pre-clinical studies present encouraging results on the therapeutic …
Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue
Human adult mesenchymal stem cells (MSCs) support the engineering of functional tissue
constructs by secreting angiogenic and cytoprotective factors, which act in a paracrine …
constructs by secreting angiogenic and cytoprotective factors, which act in a paracrine …
Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia
A Bura, V Planat-Benard, P Bourin, JS Silvestre… - Cytotherapy, 2014 - Elsevier
Background aims Non-revascularizable critical limb ischemia (CLI) is the most severe stage
of peripheral arterial disease, with no therapeutic option. Extensive preclinical studies have …
of peripheral arterial disease, with no therapeutic option. Extensive preclinical studies have …